StoryRegulatory
Elevidys receives conditional approval in Japan for Duchenne muscular dystrophy
Japan approved Elevidys under a conditional and time-limited pathway for children ages 3 to under 8 years without specific DMD gene deletions. The approval was granted by the Ministry of Health, Labour, and Welfare.